|
RAPTIVA® *** Attention RAPTIVA® Users *** If you were seriously injured by Raptiva®, or if you have a loved one who was injured by Raptiva®, please contact us immediately for a FREE potential case evaluation. Both of the above have been attributed to Raptiva®. We have Raptiva® lawyers standing by ready to speak with you. You may be entitled to compensation for your injuries, and we take all cases on a contingency fee basis, which means you do not pay for our services unless you receive an award/compensation. Do not Delay! Your rights and compensation may be lost forever if you wait. WHAT IS RAPTIVA®? Raptiva® is an approved treatment for adults with moderate-to-severe plaque psoriasis that are candidates for systemic (also referred to as whole-body) therapy/phototherapy. HOW DOES RAPTIVA® WORK? Raptiva® is provided to the patient in the form of a weekly injection. It works by actively suppressing T-cells (those blood-cells that assist in the fight against infection) in the patient’s immune system. When specifically activated, these cells migrate to the skin and can lead to the development of inflammation, in the form of scaly, red patches of skin – which are associated with psoriasis. By actively suppressing T-cells, however, Raptiva® may decrease the function of the patient’s immune system, which may then increase the patient’s potential susceptibility to infections. ARE THERE ANY POSSIBLE HEALTH RELATED RISKS? The FDA has reported on three confirmed reports (and one possible report) of a rare brain infection, called Progressive Multifocal Leukoencephalopathy (PML), in patients who had been prescribed Raptiva®. Three of the patients at issue died. All four of the patients in question had been treated with Raptiva® for more than three years. None of them were receiving other forms of treatment that might have resulted in suppression of their immune systems. Four months earlier, in October 2008, the product labeling for Raptiva® had been revised to highlight – in the form of a boxed warning - the possible risks of life-threatening infections, including PML. At the time in question, the FDA directed Genentech, the manufacturer of Raptiva®, to develop a risk evaluation and mitigation strategy (REMS) that would include a medication guide to educate patients about the possible risks posed by Raptiva®. PML is caused by a virus that specifically affects the central nervous system of the patient. PML generally manifests in patients whose immune systems have been significantly weakened. It may lead to an irreversible decline in neurological function and death. The specific symptoms that may be attributed to PML can include noticeable weakness, coordination-loss, alterations to the patient’s vision, problems in speaking, and changes to mood and personality. Currently, there is no known, effective prevention or treatment for PML. Today, the FDA strongly recommends that all health-care professionals very carefully monitor those patients who have been prescribed Raptiva® - as well as those who have discontinued usage of the drug - for any potential signs or symptoms of neurologic disease, such as PML. The FDA also recommends that health-care professionals periodically reassess the benefits of continued treatment. Patients themselves should be fully conversant with the symptoms of PML, and are advised to contact their health-care professionals immediately, in the event that they experience any symptoms that may be attributed to PML. WHAT ARE THE SPECIFIC HEALTH RELATED RISKS? The most serious risks include: If you have experienced any of these side effects, or if you have a loved one who has had a serious, adverse reaction to Raptiva®, you may have a claim for legal compensation. Contact the Mulligan Law Firm for superior legal representation. For more information on Raptiva®, see the following links: In all personal injury cases, it is extremely important that measures be taken promptly to preserve evidence, to investigate the case in question, and to enable physicians, attorneys, or other expert witnesses to thoroughly evaluate any injuries. If you or a loved one or friend is injured and may have a potential legal claim, call The Mulligan Law Firm now at 1-866-LAW-0001 (Extension 245). The initial consultation is FREE of charge, and if we agree to accept your case, we will work on a contingent fee basis, which means we get paid for our services only if there is a monetary award or recovery of funds. You may have a valid claim and be entitled to compensation for your injuries, but a lawsuit must be filed before the statute of limitations expires. Do not delay! If you delay, and the statute of limitations time period expires, you may lose all your rights to file any claim for compensation of any kind. If you are not sure or need additional help, please fill out our form on this website or call us for help at 1-866-LAW-0001 (1-866-529-0001) (Extension 245) or email us at
This e-mail address is being protected from spambots, you need JavaScript enabled to view it
This e-mail address is being protected from spambots; you need JavaScript enabled to view it. A member of our firm will call you as soon as possible to help you determine the possibility of filing a potential claim. For a FREE, no-obligation consultation with an experienced attorney regarding cases of personal injury and wrongful death, please submit our potential case intake form on this website for a free evaluation of your situation. We will respect the confidentiality of your information to the fullest extent. Form submissions are relayed to us through our highly secure servers.
|
